Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.
Fonacier
Luz
L
Winthrop University Hospital, Mineola, MN, USA.
Spergel
Jonathan
J
Charlesworth
Ernest N
EN
Weldon
David
D
Beltrani
Vincent
V
Bernhisel-Broadbent
Jan
J
Boguniewicz
Mark
M
Leung
Donald Y M
DY
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D065095:Calcineurin Inhibitors; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D008223:Lymphoma / Q000139:chemically induced; D051379:Mice; D009369:Neoplasms / Q000453:epidemiology; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011358:Product Surveillance, Postmarketing; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus